IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i15p9648-d881080.html
   My bibliography  Save this article

The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers—What Should a Urologist Really Know?

Author

Listed:
  • Rafaela Malinaric

    (Department of Urology, IRCCS Policlinic Hospital San Martino, 16132 Genoa, Italy
    Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), University of Genoa, 16132 Genoa, Italy)

  • Guglielmo Mantica

    (Department of Urology, IRCCS Policlinic Hospital San Martino, 16132 Genoa, Italy)

  • Lorenzo Lo Monaco

    (Department of Urology, IRCCS Policlinic Hospital San Martino, 16132 Genoa, Italy
    Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), University of Genoa, 16132 Genoa, Italy)

  • Federico Mariano

    (Department of Urology, IRCCS Policlinic Hospital San Martino, 16132 Genoa, Italy
    Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), University of Genoa, 16132 Genoa, Italy)

  • Rosario Leonardi

    (Department of Urology, Casa di Cura Musumeci GECAS, 95030 Gravina di Catania, Italy)

  • Alchiede Simonato

    (Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, 90133 Palermo, Italy)

  • André Van der Merwe

    (Department of Urology, Tygerberg Academic Hospital, Stellenbosch University, Cape Town 7600, South Africa)

  • Carlo Terrone

    (Department of Urology, IRCCS Policlinic Hospital San Martino, 16132 Genoa, Italy
    Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), University of Genoa, 16132 Genoa, Italy)

Abstract

The aim of this review is to analyze and describe the current landscape of bladder cancer diagnostic and surveillance biomarkers. We researched the literature from 2016 to November 2021 to find the most promising new molecules and divided them into seven different subgroups based on their function and location in the cell. Although cystoscopy and cytology are still the gold standard for diagnosis and surveillance when it comes to bladder cancer (BCa), their cost is quite a burden for national health systems worldwide. Currently, the research is focused on finding a biomarker that has high negative predictive value (NPV) and can exclude with a certainty the presence of the tumor, considering missing it could be disastrous for the patient. Every subgroup has its own advantages and disadvantages; for example, protein biomarkers cost less than genomic ones, but on the other hand, they seem to be less precise. We tried to simplify this complicated topic as much as possible in order to make it comprehensible to doctors and urologists that are not as familiar with it, as well as encourage them to actively participate in ongoing research.

Suggested Citation

  • Rafaela Malinaric & Guglielmo Mantica & Lorenzo Lo Monaco & Federico Mariano & Rosario Leonardi & Alchiede Simonato & André Van der Merwe & Carlo Terrone, 2022. "The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers—What Should a Urologist Really Know?," IJERPH, MDPI, vol. 19(15), pages 1-20, August.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:15:p:9648-:d:881080
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/15/9648/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/15/9648/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:15:p:9648-:d:881080. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.